(4 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{DTU-Denmark/mainCSS}} | {{DTU-Denmark/mainCSS}} | ||
{{DTU-Denmark/carouselCSS}} | {{DTU-Denmark/carouselCSS}} | ||
− | <html> | + | <html lang="en"> |
+ | <head> | ||
+ | <!-- Required meta tags --> | ||
+ | <meta charset="utf-8"> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no, user-scalable=0"> | ||
+ | |||
+ | |||
+ | <link rel="stylesheet" type="text/css" href="Template:DTU-Denmark/fontCSS?action=raw&ctype=text/css"> | ||
+ | |||
+ | |||
+ | |||
+ | </head> | ||
+ | <body> | ||
+ | |||
Line 23: | Line 36: | ||
− | <div class=" topimg pull-right sm-no-float col-md- | + | <div class=" topimg pull-right sm-no-float col-md-7 "> |
Line 35: | Line 48: | ||
− | <div class="pull-left col-md- | + | <div class="pull-left col-md-5 sm-text-center com-sm-12 "> |
<div class="team-heading"><h2>Integrated Human Practices</h2></div> | <div class="team-heading"><h2>Integrated Human Practices</h2></div> | ||
<div class="team-overview" style="font-size: .9em;"> | <div class="team-overview" style="font-size: .9em;"> | ||
Line 106: | Line 119: | ||
<figure> | <figure> | ||
− | <img src="https://static.igem.org/mediawiki/2019/ | + | <img src="https://static.igem.org/mediawiki/2019/1/15/T--DTU-Denmark--iHPmainfigurebigdone.png" alt="Our stakeholder analysis led us to talk to 3 different companies: Zymergen, Novozymes, and Bolt Threads. We also talked to 3 fungal experts: Peter Richard (VTT, Finland), Jens Christian Frisvad (DTU, Denmark) and Jakob Blæsbjerg (DTU, Denmark). Additionally, we addressed the public by attending Science EXPO in Copenhagen, two biotechnology camps for high school students, and teaching synthetic biology in two high schools. |
" style="width:100%; max-width: 650px; | " style="width:100%; max-width: 650px; | ||
margin-right: auto; | margin-right: auto; | ||
Line 195: | Line 208: | ||
<!-- Image Map Generated by http://www.image-map.net/ --> | <!-- Image Map Generated by http://www.image-map.net/ --> | ||
− | <img style="padding:15px;margin: 0 auto; max-width: 100%; height: auto;" src="https://static.igem.org/mediawiki/2019/ | + | <img style="padding:15px;margin: 0 auto; max-width: 100%; height: auto;" src="https://static.igem.org/mediawiki/2019/4/42/T--DTU-Denmark--newiHPMainThingy.png" border="0" width="800" height="944" orgWidth="800" orgHeight="944" alt="Interactive figure of what we learned from our stakeholders: Bolt Threads, Jens Frisvad, Jakob Blæsbjerg, Zymergen, Peter Richards, and Novozymes" usemap="#integratedhpfig3"> |
<map name="integratedhpfig3"> | <map name="integratedhpfig3"> |
Latest revision as of 02:27, 22 October 2019
Integrated Human Practices
From the very beginning of our project, our team shared a common goal – we wanted to create something meaningful. To this end, we have been in contact with important stakeholders and their advice has shaped our approach, and the project's direction.
Despite their relative anonymity, filamentous fungi are responsible for most of the industrially produced enzymes and are therefore exceptionally important to a lot of people’s everyday lives.
Project LEAP was founded in response to the acute lack of publicly available resources for synthetic biology work within filamentous fungi, and therefore aimed to expand the synthetic biology toolbox for these organisms.
Originally, the project aspired to create synthetic promoter libraries for filamentous fungi, yeast, and moss – but following valuable discussions with several companies and scientists, the team decided to develop a software that would enable the creation of promoters for any organism, and attempted to test the function of said software in Aspergilli.
Stakeholder Analysis
In March, the team looked into the impact the project could have on different stakeholders, and therefore made a stakeholder analysis, as shown in figure 2.
This stakeholder analysis reveals that companies such as Novozymes, Zymergen, and Bolt Threads are among the most important to our project, both in interest and power. This means that their opinions should be managed closely. Additionally, researchers such as Jens Frisvad (DTU, Denmark), Jakob Blæsbjerg (DTU, Denmark), and Peter Richard (VTT, Finland) could benefit from our project, making them important stakeholders. Although other iGEM teams do not have a lot of power, their interest could nevertheless be great and they should, therefore, be well informed.
The public and the DTU BlueDot program will most likely not take much interest in the project as a promoter library can be a very technical concept and not immediately usable by non-specialists. However, as DTU BlueDot is a big sponsor of the team, they are important to keep satisfied.
Based on the stakeholder analysis, we decided to contact three different biotech companies; Novozymes, Zymergen, and Bolt Threads as they all work with genetically modified filamentous fungi. We asked them how our project could influence their work, and for suggestions regarding the experiments.
We also reached out to several scientists, including Jakob Blæsbjerg from DTU and Peter Richard from VTT (Technical Research Centre) in Finland. They provided us with protocols and advice on how to grow the fungi, and how to ensure we acquired reproducible and comparable results.
Even though the public is neither very powerful nor particularly interested in the project, at least according to our stakeholder analysis, we nevertheless decided to contact high schools in order to talk to young people about synthetic biology, our project and what good we believe it can do in the world. We also partook in several events: The annual UNF (Ungdommens Naturvidenskabelige Forening) Biotech Camp; Science Expo, a large science fair in Copenhagen; and the annual Biotech Academy Camp in order to increase their knowledge and interest in a topic like synthetic biology. This is described further on Education and Engagement.
Click on the different bubbles to read more about what we learned from each stakeholder.